Having been spun-out from Oxford University, Oxford Endovascular is developing OxiFlow, a next-generation flow-diverter to reduce the risk of complications and ruptures in patients with intracranial aneurysms.
LSI USA '24 is filling fast. Secure your spot today to join Medtech and Healthtech leaders in Dana Point.
Over 30 years of international experience in medical devices including endovascular products. Leadership roles in general management, sales & marketing and mentoring. Success in fund raising, driving business growth in large corporations, SMEs and start ups, developing and bringing new products to market.
Don't miss out! Get limited time offer for LSI Europe '23 in Barcelona, Spain.